Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2011-1-18
pubmed:databankReference
pubmed:abstractText
The overall non-response rate to biologics remains 30-40% for patients with RA resistant to MTX. The objective of this study was to predict responsiveness to the anakinra-MTX combination by peripheral blood mononuclear cell gene profiling in order to optimize treatment choice.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1462-0332
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
283-92
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Gene profiling predicts rheumatoid arthritis responsiveness to IL-1Ra (anakinra).
pubmed:affiliation
Department of Rheumatology, University of Rouen, 76031 Rouen Cedex, France.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't